West End Advisors, LLC Bristol Myers Squibb CO Transaction History

West End Advisors, LLC

  • $3.92 Billion
  • Q4 2024

A detailed history of West End Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, West End Advisors, LLC holds 27 shares of BMY stock, worth $1,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27
Previous 23 17.39%
Holding current value
$1,507
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 28, 2025
BUY
$51.92 - $59.94 $207 - $239
4 Added 17.39%
27 $1,000
Q3 2024

Oct 25, 2024
SELL
$39.66 - $51.75 $79 - $103
-2 Reduced 8.0%
23 $1,000
Q2 2024

Jul 29, 2024
SELL
$40.25 - $52.99 $322 - $423
-8 Reduced 24.24%
25 $1,000
Q1 2024

May 07, 2024
BUY
$47.98 - $54.4 $47 - $54
1 Added 3.13%
33 $1,000
Q4 2023

Jan 18, 2024
BUY
$48.48 - $57.85 $96 - $115
2 Added 6.67%
32 $1,000
Q3 2023

Oct 19, 2023
BUY
$57.89 - $64.73 $1,736 - $1,941
30 New
30 $1,000
Q1 2023

Apr 28, 2023
BUY
$65.71 - $74.53 $197 - $223
3 Added 12.0%
28 $1,000
Q4 2022

Jan 31, 2023
SELL
$68.48 - $81.09 $136 - $162
-2 Reduced 7.41%
25 $1,000
Q3 2022

Oct 27, 2022
BUY
$0.13 - $76.84 $0 - $76
1 Added 3.85%
27 $2,000
Q2 2022

Jul 28, 2022
BUY
$72.62 - $79.98 $290 - $319
4 Added 18.18%
26 $2 Million
Q1 2022

Apr 26, 2022
BUY
$61.48 - $73.72 $307 - $368
5 Added 29.41%
22 $1.61 Million
Q3 2021

Oct 26, 2021
SELL
$59.17 - $69.31 $59 - $69
-1 Reduced 5.56%
17 $1.01 Million
Q2 2021

Jul 15, 2021
BUY
$61.91 - $67.42 $1,114 - $1,213
18 New
18 $1.2 Million
Q2 2019

Jul 23, 2019
SELL
$44.62 - $49.34 $31.5 Million - $34.9 Million
-706,697 Closed
0 $0
Q1 2019

May 03, 2019
BUY
$45.12 - $53.8 $3.43 Million - $4.09 Million
76,013 Added 12.05%
706,697 $33.7 Billion
Q4 2018

Jan 30, 2019
SELL
$48.76 - $63.23 $3.07 Million - $3.99 Million
-63,063 Reduced 9.09%
630,684 $32.8 Billion
Q3 2018

Nov 07, 2018
SELL
$55.19 - $62.25 $1.09 Million - $1.23 Million
-19,770 Reduced 2.77%
693,747 $43.1 Billion
Q2 2018

Jul 26, 2018
BUY
$50.53 - $62.98 $1.75 Million - $2.18 Million
34,634 Added 5.1%
713,517 $39.5 Billion
Q1 2018

May 08, 2018
SELL
$59.92 - $68.98 $612,741 - $705,389
-10,226 Reduced 1.48%
678,883 $42.9 Billion
Q4 2017

Feb 02, 2018
SELL
$59.94 - $65.35 $11.5 Million - $12.5 Million
-191,262 Reduced 21.73%
689,109 $42.2 Billion
Q3 2017

Nov 03, 2017
SELL
$55.23 - $63.74 $2.55 Million - $2.95 Million
-46,250 Reduced 4.99%
880,371 $56.1 Billion
Q2 2017

Aug 09, 2017
BUY
N/A
926,621
926,621 $51.6 Billion

Others Institutions Holding BMY

# of Institutions
2,751
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email